It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
2d
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...
The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Conagra adds an ‘On Track’ badge on packaging for 26 of its Healthy Choice frozen meals that call out GLP-1 ...
23hon MSN
Q4 2024 Management View CEO Eric Green highlighted that the company achieved 3.3% organic revenue growth in Q4 2024, marking a return to quarterly growth. Notable drivers included strong performance ...
4d
GlobalData on MSNFlowers Foods eyes GLP-1 effect as bread category weakness hits salesFlowers has documented for several quarters a consumer shift away from traditional loaves toward more “differentiated and ...
Ryals McMullian noted consumers are moving away from traditional white and wheat bread into organic, keto, gluten-free and ...
Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results